Introduction Coronary Artery Disease (CAD) remains a leading cause of global morbidity and mortality. Traditional therapeutic strategies, relying primarily on broad guidelines based on population averages, often fail to account for the significant heterogeneity observed in individual patient responses to treatment and disease progression risk. Says Dr Zachary Solomon, this conventional, generalized approach necessitates a paradigm […]